HMGA1 and pancreatic adenocarcinoma: Another promising approach for targeting HMGA1 function is the use of A/T-rich oligonucleotides in order to sequester HMGA1 and prevent target binding, which resulted in tumor size reduction in xenograft tumors originating from cultured pancreatic adenocarcinoma cells [85,86].